Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global human embryonic stem cell market reached a value of about USD 0.94 billion in 2023. The industry is further expected to grow at a CAGR of about 10.6% in the forecast period of 2024-2032 to reach a value of around USD 2.30 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is a significant regional market in the human embryonic stem cell industry due to the presence of a major number of players and the high incidence of diseases, such as diabetes, heart disease, renal failure, and osteoporosis within the region. The large share can also be attributed to the increasing public-private funding and research grants for the development of safe and effective stem cell therapy products and the growing number of clinical trials. The United States has a high incidence of other diseases, such as diabetes, heart disease, renal failure, and osteoporosis. Human embryonic stem cells have a lot of potential for treatment and could become the global standard for these diseases. Additionally, the Food & Drug Administration (FDA) has approved clinical trials, which indicated the advantageous use of stem cells in treating such diseases. Hence, these factors are expected to influence the growth of the human embryonic stem cells industry over the forecast period. Meanwhile, the Asia Pacific is expected to grow at a robust rate due to the rapidly increasing population and the enhancement of the medical infrastructure in the region.
Human embryonic stem cell comes from embryos and are pluripotent and is about 3-5 days old. It is very versatile as it has the ability to divide itself into more stem cells and can even become any type of cell in the human body and can be used to regenerate or repair any diseased tissue or organs. The primary objective of stem cell therapy is to assist doctors in the treatment of neurodegenerative diseases, diabetes, and heart disease.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on application, the human embryonic stem cell industry is segmented into:
The regional markets for human embryonic stem cell can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The advancements in technologies and growing research and development investments and research initiatives are expected to generate new opportunities for the market. As embryonic cells offer unmatched data related to a variety of diseases, researchers and scientists are increasingly leaning toward transforming the human embryonic stem cells into a range of mature cell types that represent different organs and tissues in the body. Advancements in stem culturing and derivation, along with rapid progress in laboratory technologies, are expected to play a key role in the overall growth of the global human embryonic stem cells industry during the forecast period. The rising prevalence of cardiac and malignant diseases around the world is expected to have a significant impact on demand and is anticipated to accelerate the market growth. Rapid advancements also include protocols for directed differentiation, defined culture systems, demonstration of applications in drug screening, and evaluation of therapeutic potential in treating incurable diseases. The demand for newer and better therapies to treat autoimmune, neurological, and cardiovascular diseases has resulted in an increase in research activities and funding for cell-based research, which is expected to favourably aid the growth of the human embryonic stem cell industry.
The report gives a detailed analysis of the following key players in the global human embryonic stem cell market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Application |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the market attained a value of approximately USD 0.94 billion.
The market is projected to grow at a CAGR of 10.6% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 2.30 billion by 2032.
The major drivers of the market include the rapid progress in laboratory technologies, investments by various governments, rising prevalence of cardiac and malignant diseases, and the establishment of various disease models.
The rising research and development activities, advancements in stem culturing and derivation, and rapid advancements in technologies are the key trends propelling the growth of the market.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading applications in the market are regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing.
The key players in the global human embryonic stem cell market are Astellas Pharma Inc, Stemcell Technologies Inc., Biotime, INC, and Thermo Fisher Scientific, Inc., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124